GCN2-IN-7
GCN2-IN-7 (compound 39) is an orally active and selective general control nonderepressible 2 (GCN2) inhibitor (IC50=5 nM) . GCN2-IN-7 shows anti-tumor activity in vivo[1].
Product Specifications
CAS Number
[2396465-33-9]
UNSPSC
12352005
Target
Eukaryotic Initiation Factor (eIF)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gcn2-in-7.html
Purity
99.92
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C([C@@]1(C)C[C@H](NC2=NC=C3C(N(C4=CC=C(C5=NN=C(C)S5)C=C4)N=C3Br)=N2)CC1)NC
Molecular Formula
C22H23BrN8OS
Molecular Weight
527.44
References & Citations
[1]Jackson JJ, et al. Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy. J Med Chem. 2022 Sep 20.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1404386-01 0.02 mg (E-Coli)
Recombinant Cytophaga hutchinsonii Peptide deformylase (def)
Ask
View Details MBS1404386-02 0.1 mg (E-Coli)
Recombinant Cytophaga hutchinsonii Peptide deformylase (def)
Ask
View Details 
MBS1404386-03 0.02 mg (Yeast)
Recombinant Cytophaga hutchinsonii Peptide deformylase (def)
Ask
View Details MBS1404386-04 0.1 mg (Yeast)
Recombinant Cytophaga hutchinsonii Peptide deformylase (def)
Ask
View Details MBS1404386-05 0.02 mg (Baculovirus)
Recombinant Cytophaga hutchinsonii Peptide deformylase (def)
Ask
View Details